An AI model can predict which SARS-CoV-2 variants are likely to cause new waves of infection. Current models used to predict the dynamics of viral transmission do not predict variant-specific spread.
China NMPA approves MSD’s KEYTRUDA for NSCLC stages
The approval marks the first indication of MSD’s KEYTRUDA in the earlier stages of NSCLC in China. Credit: JHVEPhoto/Shutterstock. China National Medical Products Administration (NMPA)
December 17, 2024